StockData

Alto Ingredients vs Gevo

ALTO and GEVO side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ALTO and GEVO compare

Gevo is the larger company, worth 1.5 times as much as Alto Ingredients ($405M against $279M).

Gevo grew revenue faster over the last twelve months (121% versus 1.1% for Alto Ingredients).

Alto Ingredients keeps more of each dollar of sales as profit, with a net margin of 5.5% compared with −120% at Gevo.

Alto Ingredients scores higher on the StockData Score (13 against 8 for Gevo), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricALTOGEVO
Size and price
Market cap$279M$405M
Share price$3.60$1.64
Change, 1 year76.5%−16.8%
Change, 5 years−28.7%−71.5%
Beta (5Y)−1.10−0.22
Employees390151
StockData Score
Total score13 (better)8
Valuation score4 (better)2
Growth score24 (better)
Performance score3 (better)1
Health score4 (better)1
Dividend score00
Valuation
P/E5.5×–
P/S0.3× (better)2.3×
P/B1.1× (better)1.5×
EV/EBITDA5.2×–
P/FCF5.6×–
FCF yield17.9% (better)−14.0%
Fair value$13.84$2.40
Margin of safety74.0% (better)31.5%
Growth
Revenue growth (TTM)1.1%121% (better)
Revenue growth, 5Y average0.46%96.1% (better)
Profitability
Gross margin6.8%47.3% (better)
Operating margin3.8% (better)−103%
Net margin5.5% (better)−120%
FCF margin5.3% (better)−31.9%
Return on equity22.2% (better)−57.0%
Return on invested capital9.5% (better)−29.8%
Financial health
Debt / equity0.23 (better)0.61
Net debt / EBITDA0.60–
Interest coverage3.8× (better)−8.8×
Current ratio3.19 (better)2.70
Altman Z-score1.42 (better)−2.50
Piotroski F-score7 (better)4
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions46.3%37.2%
Held by insiders9.2%4.8%
Insider net buying, 12 months$361K (better)−$2.5M
Short interest, % of float7.0%10.6%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.